𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The prognostic factors of systemic sclerosis for survival among Koreans

✍ Scribed by Jinhyun Kim; Sue Kyung Park; Ki Won Moon; Eun Young Lee; Yun Jong Lee; Yeong Wook Song; Eun Bong Lee

Publisher
Springer
Year
2009
Tongue
English
Weight
183 KB
Volume
29
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Systemic relapse of patients with osteog
Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival
✍ Gunnar Saeter; Johan HΓΈie; Anna E. Stenwig; Anna K. Johansson; Einar Hannisdal; πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 872 KB

Background. A retrospective study of long term outcome after the development of metastases from osteosarcoma was performed, with emphasis on the impact of different treatment strategies and the identification of prognostic factors. Methods. From 1975 to 1993, a population-based series of 60 patient

Sample size considerations for the evalu
Sample size considerations for the evaluation of prognostic factors in survival analysis
✍ Claudia Schmoor; Willi Sauerbrei; Martin Schumacher πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 2 views

When the role of a new prognostic factor is investigated, careful planning of an appropriate study is required. This includes an assessment of the power of the study in terms of sample sizes. An adequate analysis of the independent prognostic e!ect of a new factor has to be adjusted for the existing

Prognostic factors for survival after pa
Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region
✍ J. Hein Allema; Marcel E. Reinders; Thomas M. van Gulik; Mark J. W. Koelemay; Di πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 648 KB

Background. The aim of this study was to determine prognostic factors for survival after pancreaticoduodenectomy (PD) for carcinoma of the pancreatic head region. Methods. From 1983 to 1992.176 patients underwent PD for ampullary carcinoma (n = 67), distal bile duct carcinoma (n = 42), or pancreati